Pulmonary Medicine Featured News Feb 10, 2018 The emerging option of upper airway stimulation therapy Activation of the genioglossus muscle via stimulation of the hypoglossal nerve is a new approach for treatment of obstructive sleep apnea (OSA). In a 2014 study, stimulation was associated with a 68 percent reduction in the apnea-hypopnea index. Feb 10, 2018 Maxillomandibular advancement surgery: A classic procedure refined MMA should be considered for any patient with moderate to severe obstructive sleep apnea if surgical management is desired. At Mayo Clinic, more than half of patients with obstructive sleep apnea achieve elimination (apnea-hypopnea index less than 5). Jun 1, 2017 Center volume & hereditary hemorrhagic telangiectasia Vivek N. Iyer, M.D., an assistant professor of medicine in the Division of Pulmonary and Critical Care Medicine at Mayo Clinic in Rochester, Minnesota, describes the rare disease hereditary hemorrhagic telangiectasia. Feb 10, 2018 The gaining popularity of oral appliances Oral appliances can improve important outcomes in selected patients with more severe obstructive sleep apnea (OSA). Innovations include compliance recorders to help in long-term follow-up and emerging technologies to remotely adjust the appliance to optimize upper airway patency. Clinical Trials See All Impulse Oscillometry in Idiopathic Subglottic StenosisCap Rochester, Minn. A Study of Beta-Blockers for the Prevention of Acute Worsening of Chronic Obstructive Pulmonary Disease Rochester, Minn. Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil Jacksonville, Fla. Publications PRINT EDITION See the latest edition plus past issues More News 1 New definitions and diagnoses in interstitial pneumonia 2 Lung transplantation: Challenges and opportunities 3 Anti-fibrotic therapy in the treatment of IPF: Ongoing concerns and current practices 4 Care of the patient with lung cancer at Mayo Clinic: Mayo Clinic tumor board provides multidisciplinary expertise 5 Advances in lung cancer immunotherapy and management of immune-mediated adverse events Medical Professionals Pulmonary Medicine